KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Discontinued OperationsCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Clover Health Investments (CLOV) Cash from Investing Activities (2020 - 2025)

Clover Health Investments (CLOV) has disclosed Cash from Investing Activities for 6 consecutive years, with -$35.0 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Cash from Investing Activities fell 2331.9% year-over-year to -$35.0 million, compared with a TTM value of $4.1 million through Dec 2025, up 621.42%, and an annual FY2025 reading of $4.1 million, up 621.42% over the prior year.
  • Cash from Investing Activities was -$35.0 million for Q4 2025 at Clover Health Investments, down from -$5.4 million in the prior quarter.
  • Across five years, Cash from Investing Activities topped out at $170.9 million in Q2 2021 and bottomed at -$257.5 million in Q1 2021.
  • Average Cash from Investing Activities over 5 years is -$9.8 million, with a median of $6.9 million recorded in 2024.
  • Peak annual rise in Cash from Investing Activities hit 1306.42% in 2021, while the deepest fall reached 16256.33% in 2021.
  • Year by year, Cash from Investing Activities stood at -$106.5 million in 2021, then soared by 111.88% to $12.7 million in 2022, then surged by 561.05% to $83.7 million in 2023, then plummeted by 101.72% to -$1.4 million in 2024, then crashed by 2331.9% to -$35.0 million in 2025.
  • Business Quant data shows Cash from Investing Activities for CLOV at -$35.0 million in Q4 2025, -$5.4 million in Q3 2025, and $35.6 million in Q2 2025.